Dr. Gunn, a cardiothoracic surgeon, gained an interest in ECMO during his residency and fellowship during the COVID-19 pandemic.
ECMO is a portable heart-lung machine which deoxygenates blood. Traditionally used as a last resort, the device was effective in treating COVID-19 patients, according to the report.
“In my last year of surgical residency, I worked in a hospital where most of the patients we treated were unvaccinated against COVID-19 and many of them required ECMO for survival,” Dr. Gunn said in the report. “I learned alongside my mentor, who happened to be a co-inventor of ECMO, which further fueled my understanding and interest in its use.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
